4.6 Review

The Impact of Aging in Acute Respiratory Distress Syndrome: A Clinical and Mechanistic Overview

Journal

FRONTIERS IN MEDICINE
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2020.589553

Keywords

acute respiratory distress syndrome; acute lung injury; aging; immunosenescence; biomarkers

Funding

  1. Department for the Economy (Northern Ireland)
  2. Cystic Fibrosis Foundation [WELDON18G0]
  3. MaterHospital Young Philanthropist (YP) Trustees
  4. Medical Research Council [MR/T016760/1, MR/P022847/1]
  5. MRC [MC_G1002460, MR/T016760/1, MR/P022847/1] Funding Source: UKRI

Ask authors/readers for more resources

Acute respiratory distress syndrome (ARDS) is associated with increased morbidity and mortality in the elderly population (>= 65 years of age). Additionally, age is widely reported as a risk factor for the development of ARDS. However, the underlying pathophysiological mechanisms behind the increased risk of developing, and increased severity of, ARDS in the elderly population are not fully understood. This is compounded by the significant heterogeneity observed in patients with ARDS. With an aging population worldwide, a better understanding of these mechanisms could facilitate the development of therapies to improve outcomes in this population. In this review, the current clinical evidence of age as a risk factor and prognostic indicator in ARDS and the potential underlying mechanisms that may contribute to these factors are outlined. In addition, research on age-dependent treatment options and biomarkers, as well as future prospects for targeting these underlying mechanisms, are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available